Insurer Stocks Soar After CMS Finalizes 2027 Medicare Payments
CMS boosts 2027 Medicare payments 2.5%, giving insurers $13B+, keeping plans stable and seniors’ benefits solid. Stocks jump.
/ 7 items
#HUM↓
Humana's 2026 Profit Forecast Falls Short of Expectations
Humana predicts lower 2026 profits due to reduced Medicare ratings, projecting at least $9 per share against Wall Street's $11.92 estimate amid market challenges.
Morgan Stanley Cuts Humana Rating Amid Medicare Advantage Concerns
Morgan Stanley downgraded Humana to Underweight, citing policy risks and disappointing Medicare Advantage updates, with a new price target of $174.
Trump Administration Proposes Near-Flat Medicare Advantage Rates, Disappointing Insurers
Trump's CMS proposes minimal 0.09% Medicare payment increase for 2027, far below Wall Street's 4-6% expectations, while eliminating controversial billing practices.
Humana Beats Q3 Profit Expectations Despite Rising Medical Costs
Humana's Q3 earnings surpass Wall Street forecasts with $3.24 adjusted EPS. Medicare Advantage membership outlook improves while company manages rising healthcare costs.
Molina Healthcare Cuts Full-Year Outlook After Marketplace Weakness
Molina Healthcare drastically lowered its 2025 profit outlook, blaming unexpectedly high medical costs, especially in its Marketplace (Obamacare) business.